NCT04885309

Brief Summary

In this prospective randomized controlled study, the effects of obturator nerve block (ONB) on obturator reflex, incomplete resection, perforation, tumor recurrence and progression, presence of muscle tissue in the specimen, need for second transurethral resection of bladder tumours (TURBT) and postoperative complications were investigated in patients who underwent TURBT for intermediate and high risk lateral wall non-muscle invasive bladder tumours (NMIBC).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 10, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 13, 2021

Completed
Last Updated

May 13, 2021

Status Verified

May 1, 2021

Enrollment Period

1.2 years

First QC Date

May 10, 2021

Last Update Submit

May 10, 2021

Conditions

Keywords

Non-muscle invasive bladder cancerObturator nerve blockTransurethral resection

Outcome Measures

Primary Outcomes (1)

  • Rate of Obturator Reflex

    Rate of patients who had an obturator reflex during the operation

    One year

Study Arms (2)

Obturator Nerve Block + Spinal Anaesthesia

ACTIVE COMPARATOR

Patients who underwent obturator nerve block with spinal anesthesia prior to TURBT

Procedure: Nerve Stimulator-guided Obturator Nerve Block

Spinal Anaesthesia

SHAM COMPARATOR

Patients who underwent spinal anesthesia prior to TURBT

Procedure: Nerve Stimulator-guided Obturator Nerve Block

Interventions

Following the confirmation of spinal anesthesia level in the patients in the ONB group while in the lithotomy position, ONB was applied unilaterally or bilaterally, depending on the tumor position. A needle with a nerve stimulator was advanced vertically 2 cm below and 2 cm from the pubic tubercle. The needle is inserted through the skin and into the lower ramus of the pubic bone. When contraction was observed in the adductor muscle groups and the aspiration was negative, 10 mL 0.25% levobupivacaine at 0.3-0.5 mA was administered. The operation was started 10 minutes after the injection. TURBT operations were performed with a 30 degree optic and a 26 F bipolar resectoscope. All spinal anesthesia and ONB procedures were performed by the same anesthesia team. All TURBT operations were performed by the same surgeon.

Obturator Nerve Block + Spinal AnaesthesiaSpinal Anaesthesia

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Lateral wall intermediate and high risk non-muscle invasive bladder cancer

You may not qualify if:

  • Low risk non-muscle invasive bladder cancer
  • Contraindications for spinal anesthesia
  • History of allergy to local anesthetic agents
  • Coagulopathy
  • Neuromuscular diseases affecting the central nervous system
  • Obturator nerve injury

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Training and Research Hospital

Ankara, Altindag, 06230, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Urinary Bladder NeoplasmsNon-Muscle Invasive Bladder Neoplasms

Condition Hierarchy (Ancestors)

Urologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteNeoplasmsFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrinary Bladder DiseasesUrologic DiseasesMale Urogenital DiseasesCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic Type

Study Officials

  • Ali Kaan Yildiz

    Ankara Training and Resarch Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 10, 2021

First Posted

May 13, 2021

Study Start

January 1, 2018

Primary Completion

April 1, 2019

Study Completion

April 1, 2021

Last Updated

May 13, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

Locations